See All Slides - tctmd.com

Slides

Presentation TCT 2013

Radial Artery Access for Endovascular Intervention: Feasibility, Limitations, and Tips

Presenter: Michael Rinaldi

October 28, 2013

Presentation TCT 2013

Editorial Comment: Thrombectomy Device Use and Selection After the TASTE Trial

Presenter: Thomas Stuckey

October 28, 2013

Presentation TCT 2013

Case #4: A Retrograde Failure that Changed my Practice

Presenter: Mauro Carlino

October 28, 2013

Presentation TCT 2013

Case Presentation: TAVR in a Moderate Risk Aortic Stenosis Patient

Presenter: Alexey Protopopov

October 28, 2013

Presentation TCT 2013

Editorial Comment: When to Acutely Perform Multivessel PCI in STEMI

Presenter: George Dangas

October 28, 2013

Presentation TCT 2013

Interventional Approaches to Type 2 Endoleaks Following Successful EVAR for AAA

Presenter: Michael Dake

October 28, 2013

Presentation TCT 2012

PARADOX: A Prospective, Randomized Trial of Clopidogrel and Prasugrel in Smokers and Non-Smokers

Presenter: Paul Gurbel

October 22, 2012

Presentation TCT 2012

Hypertension: Renal Denervation

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Presenter: Jeffrey Kuvin

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Advertisement

Slides

Radial Artery Access for Endovascular Intervention: Feasibility, Limitations, and Tips

Editorial Comment: Thrombectomy Device Use and Selection After the TASTE Trial

Case #4: A Retrograde Failure that Changed my Practice

Case Presentation: TAVR in a Moderate Risk Aortic Stenosis Patient

Editorial Comment: When to Acutely Perform Multivessel PCI in STEMI

Interventional Approaches to Type 2 Endoleaks Following Successful EVAR for AAA

PARADOX: A Prospective, Randomized Trial of Clopidogrel and Prasugrel in Smokers and Non-Smokers

Hypertension: Renal Denervation

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content